• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Precision Biosciences Inc (NQ: DTIL )

    8.400 -0.060 (-0.71%)
    Streaming Delayed Price Updated: 4:00 PM EST, Nov 6, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Precision Biosciences Inc

    < Previous 1 2 3 4 5 6 7 8 9 Next >
    12 Health Care Stocks Moving In Tuesday's Pre-Market Session
    Via Benzinga
    Precision BioSciences Announces Publication in Nature Metabolism Supporting ARCUS® In Vivo Gene Editing as a Potentially Curative Treatment for Mitochondrial Diseases
    From Precision BioSciences, Inc.
    Via Business Wire
    Precision BioSciences to Present at Hep-DART 2023
    From Precision BioSciences, Inc.
    Via Business Wire
    Earnings Outlook For Precision BioSciences
    Via Benzinga
    What 4 Analyst Ratings Have To Say About Precision BioSciences
    Via Benzinga
    The Latest Analyst Ratings for Precision BioSciences
    Via Benzinga
    Precision BioSciences Announces Grant of Inducement Award Under Nasdaq Listing Rule 5635(c)(4)
    From Precision BioSciences, Inc.
    Via Business Wire
    Sidoti Events, LLC’s Virtual November Micro-Cap Conference
    Via ACCESSWIRE
    Precision BioSciences Presents Late-Breaking Data Highlighting Preclinical Efficacy and Safety of PBGENE-HBV for Chronic Hepatitis B at AASLD’s The Liver Meeting 2023
    From Precision BioSciences, Inc.
    Via Business Wire
    Precision BioSciences to Present at Upcoming Sidoti Conference
    From Precision BioSciences, Inc.
    Via Business Wire
    Precision BioSciences Announces Late-Breaking Poster Presentation at the American Association for the Study of Liver Diseases (AASLD) Annual Meeting
    From Precision BioSciences, Inc.
    Via Business Wire
    Precision BioSciences Reports Third Quarter 2023 Financial Results and Provides Business Update
    From Precision BioSciences, Inc.
    Via Business Wire
    12 Health Care Stocks Moving In Wednesday's Intraday Session
    Via Benzinga
    Precision BioSciences to Report Third Quarter Results on November 7, 2023
    From Precision BioSciences, Inc.
    Via Business Wire
    Precision BioSciences Presents Preclinical Data Highlighting Capabilities of ARCUS for Gene Insertion and Excision at the European Society of Gene & Cell Therapy (ESGCT) 30th Annual Congress
    From Precision BioSciences, Inc.
    Via Business Wire
    Precision BioSciences to Present at Upcoming H.C. Wainwright 4th Annual Hepatitis B Virus Conference
    From Precision BioSciences, Inc.
    Via Business Wire
    Precision BioSciences to Present at the European Society of Gene & Cell Therapy (ESGCT) 30th Annual Congress
    From Precision BioSciences, Inc.
    Via Business Wire
    Precision BioSciences Receives U.S. Patent Allowance Covering PBGENE-PMM for m.3243-Associated Mitochondrial Diseases
    From Precision BioSciences, Inc.
    Via Business Wire
    Why Femasys Shares Are Trading Higher By Over 200%; Here Are 20 Stocks Moving Premarket
    Gainers Femasys Inc. (NASDAQ: FEMY) shares rose 201% to $1.00 in pre-market trading after the company received FDA 510(k) clearance for FemaSeed, an infertility treatment. 
    Via Benzinga
    Exposures Product Safety
    Precision BioSciences Hosts Virtual R&D Day Highlighting its Proprietary ARCUS Technology and Recent In Vivo Gene Editing Program Developments
    From Precision BioSciences, Inc.
    Via Business Wire
    Precision BioSciences to Attend and Present at Upcoming September Investor Conferences
    From Precision BioSciences, Inc.
    Via Business Wire
    Precision BioSciences to Host In Vivo Gene Editing R&D Day on September 12, 2023
    From Precision BioSciences, Inc.
    Via Business Wire
    What Is Precision BioSciences CAR T Pipeline Value? Analyst Lowers Price Target To Justify Valuation
    Wednesday, Precision BioSciences Inc (NASDAQ: DTIL) announced the completion of a strategic transaction with Imugene Limited for global rights to Azercabtagene Zapreleucel (azer-cel), Precision's lead... 
    Via Benzinga
    Why Is Precision BioSciences Stock Soaring Today?
    Precision BioSciences Inc (NASDAQ: DTIL) announced the completion of a strategic transaction with Imugene Limited for global rights to Azercabtagene Zapreleucel (azer-cel), Precision's lead allogeneic... 
    Via Benzinga
    12 Health Care Stocks Moving In Wednesday's Pre-Market Session
    Via Benzinga
    Why DLocal Shares Are Trading Higher By 25%; Here Are 20 Stocks Moving Premarket
    Gainers 
    Via Benzinga
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
    Investors will want to get ready for another busy day of trading as we cover the biggest pre-market stock movers for Wednesday! 
    Via InvestorPlace
    Precision BioSciences Completes Strategic Transaction with Imugene for Azer-Cel in Cancer
    From Precision BioSciences, Inc.
    Via Business Wire
    Precision BioSciences Reports Second Quarter 2023 Financial Results and Provides Business Update
    From Precision BioSciences, Inc.
    Via Business Wire
    Earnings Scheduled For August 4, 2023
    Companies Reporting Before The Bell • WPP (NYSE:WPP) is projected to report earnings for its first quarter. • Anglogold Ashanti (NYSE:AU) is likely to report earnings for its first quarter. 
    Via Benzinga
    < Previous 1 2 3 4 5 6 7 8 9 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.